Check Cap Ltd (CHEK) - Net Assets

Latest as of June 2025: $-1.45 Million USD

Based on the latest financial reports, Check Cap Ltd (CHEK) has net assets worth $-1.45 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($377.00K) and total liabilities ($1.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore CHEK operating cash flow to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric Value
Current Net Assets $-1.45 Million
% of Total Assets -384.62%
Annual Growth Rate N/A
5-Year Change -102.86%
10-Year Change -113.93%
Growth Volatility 157.04

Check Cap Ltd - Net Assets Trend (2012–2025)

This chart illustrates how Check Cap Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Check Cap Ltd balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Check Cap Ltd (2012–2025)

The table below shows the annual net assets of Check Cap Ltd from 2012 to 2025. For live valuation and market cap data, see Check Cap Ltd (CHEK) total market value.

Year Net Assets Change
2025-12-31 $-1.45 Million 0.00%
2024-12-31 $-1.45 Million -106.12%
2023-12-31 $23.69 Million -42.66%
2022-12-31 $41.31 Million -18.50%
2021-12-31 $50.69 Million +209.51%
2020-12-31 $16.38 Million +162.72%
2019-12-31 $6.23 Million -52.16%
2018-12-31 $13.03 Million +120.66%
2017-12-31 $5.91 Million -43.26%
2016-12-31 $10.41 Million -17.72%
2015-12-31 $12.65 Million +467.94%
2014-12-31 $2.23 Million +86.99%
2013-12-31 $1.19 Million -76.78%
2012-12-31 $5.13 Million --

Equity Component Analysis

This analysis shows how different components contribute to Check Cap Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 15152000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $83.75 Million %
Other Components $84.81 Million %
Total Equity $-1.45 Million 100.00%

Check Cap Ltd Competitors by Market Cap

The table below lists competitors of Check Cap Ltd ranked by their market capitalization.

Company Market Cap
Together Startup Network Ltd
TA:TGTR
$9.43 Million
NeuroMetrix Inc
NASDAQ:NURO
$9.43 Million
Pacific Strategic Financial
JK:APIC
$9.44 Million
HK Metals Utama Tbk PT
JK:HKMU
$9.44 Million
SOS Limited
NYSE:SOS
$9.41 Million
Battery Age Minerals Ltd
AU:BM8
$9.40 Million
CARTIER SILVER CORP
F:2CI0
$9.39 Million
Lease IT Public Company Limited
BK:LIT
$9.39 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Check Cap Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -1,450,000 to -1,450,000, a change of 0.
  • Net loss of 25,149,000 reduced equity.
  • Other factors increased equity by 25,149,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-25.15 Million -1734.41%
Other Changes $25.15 Million +1734.41%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Check Cap Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 $206.33 $139.00 x
2013-12-31 $47.91 $139.00 x
2014-12-31 $44.86 $139.00 x
2015-12-31 $254.70 $139.00 x
2016-12-31 $172.27 $139.00 x
2017-12-31 $81.17 $139.00 x
2018-12-31 $64.22 $139.00 x
2019-12-31 $15.61 $139.00 x
2020-12-31 $10.79 $139.00 x
2021-12-31 $12.24 $139.00 x
2022-12-31 $7.28 $139.00 x
2023-12-31 $4.05 $139.00 x
2024-12-31 $-0.25 $139.00 x
2025-12-31 $-0.25 $139.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Check Cap Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-105.75%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 -72.55% 0.00% 0.00x 1.66x $-4.23 Million
2013 -335.43% 0.00% 0.00x 4.51x $-4.11 Million
2014 -183.03% 0.00% -0.10x 3.50x $-4.30 Million
2015 -97.17% -7104.05% 0.01x 1.21x $-13.55 Million
2016 -84.81% -3617.21% 0.02x 1.18x $-9.87 Million
2017 -165.47% 0.00% 0.00x 1.34x $-10.36 Million
2018 -81.27% 0.00% 0.00x 1.18x $-11.89 Million
2019 -221.94% 0.00% 0.00x 1.51x $-14.46 Million
2020 -84.54% 0.00% 0.00x 1.20x $-15.48 Million
2021 -33.94% 0.00% 0.00x 1.10x $-22.27 Million
2022 -46.25% 0.00% 0.00x 1.10x $-23.24 Million
2023 -74.17% 0.00% 0.00x 1.06x $-19.94 Million
2024 0.00% 0.00% 0.00x 0.00x $-25.00 Million
2025 0.00% 0.00% 0.00x 0.00x $-25.00 Million

Industry Comparison

This section compares Check Cap Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $892,349,604
  • Average return on equity (ROE) among peers: -37.69%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Check Cap Ltd (CHEK) $-1.45 Million -72.55% N/A $9.42 Million
Agilent Technologies Inc (A) $6.74 Billion 6.44% 0.89x $32.79 Billion
Advanced Biomed Inc. Common Stock (ADVB) $976.24K -188.19% 0.03x $6.34 Million
Applied DNA Sciences Inc (APDN) $-11.94 Million 0.00% 0.00x $3.99 Million
Biodesix Inc (BDSX) $-198.03 Million 0.00% 0.00x $79.44 Million
bioAffinity Technologies, Inc. (BIAF) $-15.79 Million 0.00% 0.00x $7.42 Million
Biocept Inc. (BIOCQ) $23.69 Million -75.16% 1.00x $262.00
BillionToOne, Inc. Class A Common Stock (BLLN) $480.11 Million 1.55% 0.32x $3.77 Billion
Burning Rock Biotech Ltd (BNR) $1.16 Billion -83.85% 0.37x $107.26 Million
CareDx Inc (CDNA) $-147.20 Million 0.00% 0.00x $1.00 Billion

About Check Cap Ltd

NASDAQ:CHEK USA Diagnostics & Research
Market Cap
$813.28 Million
Market Cap Rank
#27180 Global
#5486 in USA
Share Price
$139.00
Change (1 day)
+0.72%
52-Week Range
$0.60 - $179.00
All Time High
$792.00
About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.